Related Experiment Video
Updated: Apr 28, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Mortality Rate and Related Risk Factors in Hospitalized Coronavirus Disease 2019 Patients with Diabetes: A
Atousa Najmaldin1, Ali Gohari2, Hoda Aryan1
1Department of Internal Medicine, Semnan University of Medical Sciences, Semnan. Iran.
Insights
Patients with diabetes mellitus (DM) face a higher risk of severe COVID-19 and increased mortality. This study found that DM significantly elevates COVID-19 mortality risk, with factors like low oxygen saturation worsening outcomes.
Area of Science:
- Medical Research
- Infectious Diseases
- Endocrinology
Background:
- The global COVID-19 pandemic poses significant health risks, particularly for individuals with chronic conditions like diabetes mellitus (DM).
- Patients with DM are identified as a high-risk group for severe COVID-19 outcomes.
- Understanding COVID-19 mortality in diabetic populations is crucial for public health strategies.
Purpose of the Study:
- To investigate the mortality rate of COVID-19 among patients diagnosed with diabetes mellitus.
- To identify risk factors associated with increased mortality in diabetic COVID-19 patients.
Main Methods:
- A cross-sectional study was conducted with 211 diabetic patients diagnosed with COVID-19.
- Data collected included patient demographics, clinical characteristics, and treatment details.
- Multivariate logistic regression was used to analyze mortality predictors.
Main Results:
- The mean age of the diabetic patients was 64.92 years, with 51.7% being male.
- Overall mortality among diabetic COVID-19 patients was 20.9%.
- Hypertension and ischemic heart disease were common comorbidities. Cardiovascular disease presence significantly increased mortality. Cough on arrival predicted reduced mortality, while oxygen saturation below 90% significantly increased it.
Conclusions:
- Diabetes mellitus increases the likelihood of contracting COVID-19 and is associated with a higher mortality rate.
- Specific clinical indicators like low oxygen saturation are critical predictors of mortality in diabetic patients with COVID-19.
Background:
The outbreak of the new coronavirus disease 2019 (COVID-19) is majorly threatening the health of people worldwide. Since patients with chronic diseases, including diabetes mellitus (DM), are among the main groups at risk of severe COVID-19; hence, this study was aimed to investigate the mortality rate of COVID-19 among patients with DM.
Materials And Methods:
This cross-sectional study was performed on 211 DM patients with COVID-19 who were referred to Educational Kowsar Hospital in Semnan, Iran. After a definitive diagnosis of COVID-19, basic characteristics, including gender, weight, height, and clinical information (such as initial signs and symptoms, underlying diseases, complications during hospitalization, and type of treatment received) were collected.
Results:
The mean age of patients was 64.92±12.7 years, and 51.7% were male. Totally 20.9% of patients were expired. The most frequent underlying diseases were hypertension and ischemic heart disease. The simultaneous presence of cardiovascular diseases in DM patients with COVID-19 was correlated with a considerable mortality rate increment. Cough on arrival significantly predicted mortality reduction to less than one-third (P=0.009). Also, oxygen saturation of less than 90% on arrival was a significant predictor of an increase in mortality by more than double (P0.001).
Conclusion:
According to the results of multivariate logistic regression, it was found that DM can increment the probability of contracting COVID-19, and the rate of mortality was also higher in these patients.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypoglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis